Jazz Pharmaceuticals (JAZZ) Tax Provisions (2012 - 2026)

Jazz Pharmaceuticals' Tax Provisions history runs 15 years deep, the most recent figure standing at $6.1 million for Q1 2026.

• In Q1 2026, Tax Provisions rose 134.27% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at -$248.5 million (down 105.57% YoY), while the FY2025 annual figure was -$272.4 million, down 197.94% from the prior year.
• Tax Provisions was $6.1 million for Q1 2026 at Jazz Pharmaceuticals, up from $5.0 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $11.7 million in Q1 2024 to a low of -$242.4 million in Q3 2025.
• Historically, Tax Provisions has averaged -$37.4 million across 5 years, with a median of -$17.8 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Tax Provisions tumbled 3164.8% in 2023, then soared 176.35% in 2024.
• A 5-year view of Tax Provisions shows it stood at -$100.0 million in 2022, then surged by 66.9% to -$33.1 million in 2023, then slumped by 74.9% to -$57.9 million in 2024, then jumped by 108.63% to $5.0 million in 2025, then gained by 22.0% to $6.1 million in 2026.
• The last three Tax Provisions figures came in at $6.1 million (Q1 2026), $5.0 million (Q4 2025), and -$242.4 million (Q3 2025), per Business Quant data.